[1]
K. Halahleh, “Ruxolitinib Plus Extracorporeal Photopheresis for Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease”, J Clin Med Res, vol. 17, no. 12, pp. 698–707, Jan. 2025, doi: 10.14740/jocmr6385.